Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 182   

Articles published

PFE 30.40 -0.18 (-0.59%)
price chart
Why I'd Avoid Pfizer Inc. Stock Despite the Dividend
Pfizer's problem in the clinic is uncertainty regarding its ability to generate new blockbuster drugs. The company decided, along with almost every other Big Pharma simultaneously, to go after novel oncology and high cholesterol drugs to replace former ...
Related articles »  
Is It Time to Buy Pfizer Inc.'s Stock?
Since the recession ended, shareholders in Pfizer (NYSE: PFE ) , the world's largest pharmaceutical company by revenue, have seen their shares more than double.
Related articles »  
MedGenesis Enters Into Agreement with Pfizer Inc. for Potential Treatments for ...
VICTORIA, BRITISH COLUMBIA, Sep 16, 2014 (Marketwired via COMTEX) -- MedGenesis Therapeutix Inc. ("MedGenesis"), a privately held biotechnology company focused on the development and precision delivery of definitive treatments for neurologic ...
Related articles »  
3 Reasons Pfizer Inc.'s Stock Could Fall
Pfizer (NYSE: PFE ) may be the largest pharmaceutical company in the world, but size isn't everything when it comes to developing and selling drugs.
Related articles »  
Pfizer Inc. (PFE) Tops DJIA Gainers for September 15
The Dow closed at 17,031.10 on Monday, which is a 0.26% move from yesterday's close. Pfizer Inc. led all gainers with a 1.67% jump.
Investors Purchase High Volume of Put Options on Pfizer (PFE)  Watch List News (press release)
Related articles »  
Pfizer Drops Plan to Acquire AstraZeneca; Considering Other Options
It seems like Pfizer Inc. (PFE) has already given up hopes to acquire AstraZeneca plc (ADR) (AZN). The company last made a $116 billion proposal to buy the London-based drug maker only to be spurned by AstraZeneca for undervaluing the company.
Stock Alert: Pfizer Inc. (NYSE:PFE), AstraZeneca PLC (NYSE:AZN), Eli Lilly ...  WallStreet Scope
Related articles »  
2 Compelling Reasons To Buy Pfizer (PFE)
Pfizer shares are down nearly 5% this year but the pullback should be seen as a buying opportunity. Pfizer is strengthening its vaccine portfolio, which will help in reducing reliance on Prevnar 13.
Will Pfizer Inc. (NYSE:PFE) Make An Attempt Acquire Astrazeneca Plc (ADR ...  WallStreetPR
Pfizer Inc. (NYSE:PFE) 's Yield Is Relatively Low Risk As Merck & Co ...  eMarketsDaily
Related articles »  
Key Growth Drivers For Pfizer Inc.
ENBREL was released as a co-promotion campaign by Pfizer and Amgen, Inc. (AMGN) last year. Pfizer's rights to ENBREL expired last year, after which it went back to Amgen.
Pfizer Signs Agreement To Market Novartis' Respiratory Inhalers In UK
Pfizer Inc. (PFE) has entered into an agreement with Novartis AG (ADR) (NVS), under which Pfizer's UK-based business, officially named Pfizer Limited, will be responsible for the commercialization of Novartis' two respiratory inhalers, Seebri ...
Vectura Says Pfizer To Commercialize Two Treatments In UK  London South East
Related articles »  
Interesting January 2015 Stock Options for Pfizer
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer PFE +0.76% Inc (NYSE: PFE). So this week we highlight one interesting put contract, and one interesting call contract, from ...
Related articles »